Measuring inflammation in IBD with an OSM-ostat
- PMID: 28469037
- DOI: 10.1126/scitranslmed.aan3777
Measuring inflammation in IBD with an OSM-ostat
Abstract
Oncostatin M is elevated in inflammatory bowel disease, wherein it may promote intestinal stroma cell inflammation and predict nonresponsiveness to anti-TNF therapy.
Copyright © 2017, American Association for the Advancement of Science.
Comment on
-
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.Nat Med. 2017 May;23(5):579-589. doi: 10.1038/nm.4307. Epub 2017 Apr 3. Nat Med. 2017. PMID: 28368383 Free PMC article.
Similar articles
-
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial Myofibroblasts.Inflamm Bowel Dis. 2024 Nov 4;30(11):2162-2173. doi: 10.1093/ibd/izae098. Inflamm Bowel Dis. 2024. PMID: 38717842
-
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.Nat Med. 2017 May;23(5):579-589. doi: 10.1038/nm.4307. Epub 2017 Apr 3. Nat Med. 2017. PMID: 28368383 Free PMC article.
-
TNF receptor associated factor 5 controls oncostatin M-mediated lung inflammation.Biochem Biophys Res Commun. 2018 May 15;499(3):544-550. doi: 10.1016/j.bbrc.2018.03.186. Epub 2018 Apr 2. Biochem Biophys Res Commun. 2018. PMID: 29596835
-
Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD).Expert Opin Ther Targets. 2019 Nov;23(11):943-954. doi: 10.1080/14728222.2019.1677608. Epub 2019 Oct 15. Expert Opin Ther Targets. 2019. PMID: 31587593 Review.
-
The oncostatin M-stromal cell axis in health and disease.Scand J Immunol. 2018 Sep;88(3):e12694. doi: 10.1111/sji.12694. Epub 2018 Jul 4. Scand J Immunol. 2018. PMID: 29926972 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources